Drugs Made In America Acquisition Corp. Ordinary Shares

DMAAR

NASDAQ

Financial Services

Shell Companies

Fort Lauderdale, FL, US2 employeesdmaacorp.com

$0.06

+0.00(0.00%)

Mkt Cap $1M

$0.04

$0.23

52-Week Range

At a Glance

AI-generated

8-K

Drugs Made In America Acquisition Corp. entered into a Definitive Interim Investment and Sponsor Transition Agreement with BV Advisory Partners, LLC on March 23, 2026, issuing a $100,000 interim convertible note as the first tranche of a contemplated $500,000 financing. The proceeds are intended for expenses related to a potential business combination, and the investor has introduced a specific target opportunity involving an enterprise technology platform.

$1M

Market Cap

—

Revenue

$2.0B

Net Income

Employees2

Fundamentals

How The Business Makes Money

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Industry Shell Companies

Activity

What Changed Recently

Management Change

Mar 5, 2026

. Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previou

Material Agreement+3 More

Mar 26, 2026

Entry into a Material Definitive Agreement. On March 23, 2026, Drugs Made In America Acquisition Corp. (the “ Company ”) issued an interim convertible note (the

Other Event

Mar 5, 2026

. Other Events. As previously reported in the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2026, Drugs Made In Ameri

Company Profile

CIK0002028614

ISINKYG2847J1123

Address1 East Broward Blvd Suite 700, Fort Lauderdale, FL, 33301, US

SEC EDGAR